CIAM
CATX icon

Caitong International Asset Management’s Perspective Therapeutics CATX Stock Holding History

Caitong International Asset Management’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.41K Sell
339
-30,288
-99% -$128K ﹤0.01% 1322
2025
Q4 		$84.2K Buy
+30,627
New +$87.4K 0.02% 501
2025
Q2 		– Sell
-895
Closed -$1.91K – 2044
2025
Q1 		$1.91K Buy
895
+780
+678% +$2.34K ﹤0.01% 1368
2024
Q4 		$367 Buy
+115
New +$939 ﹤0.01% 1504

Other funds holding CATX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Caitong International Asset Management's CATX Position: Q1 2026 in Review

Caitong International Asset Management reduced its Perspective Therapeutics (CATX) stake by 99% in Q1 2026, selling an estimated $128K and leaving 339 shares worth $1.41K. The position accounts for ﹤0.01% of the portfolio, ranked #1322.

Caitong International Asset Management first reported a position in CATX in Q4 2024 and has held it in 4 quarters since. The position peaked at $84.2K in Q4 2025. 138 funds tracked by Wall St. Rank hold CATX as of Q1 2026.

  • Caitong International Asset Management held 339 shares of Perspective Therapeutics worth $1.41K as of Q1 2026.
  • Caitong International Asset Management sold 30,288 Perspective Therapeutics shares in Q1 2026, an estimated $128K.
  • Perspective Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1322 holding.
  • Caitong International Asset Management first reported a position in Perspective Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • Caitong International Asset Management's Perspective Therapeutics position peaked at $84.2K in Q4 2025.
  • 138 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.